441 related articles for article (PubMed ID: 16537614)
1. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.
Hiraragi H; Kim SJ; Phipps AJ; Silic-Benussi M; Ciminale V; Ratner L; Green PL; Lairmore MD
J Virol; 2006 Apr; 80(7):3469-76. PubMed ID: 16537614
[TBL] [Abstract][Full Text] [Related]
2. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.
Bartoe JT; Albrecht B; Collins ND; Robek MD; Ratner L; Green PL; Lairmore MD
J Virol; 2000 Feb; 74(3):1094-100. PubMed ID: 10627519
[TBL] [Abstract][Full Text] [Related]
3. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion.
Silverman LR; Phipps AJ; Montgomery A; Ratner L; Lairmore MD
J Virol; 2004 Apr; 78(8):3837-45. PubMed ID: 15047799
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo functional analysis of human T cell lymphotropic virus type 1 pX open reading frames I and II.
Lairmore MD; Albrecht B; D'Souza C; Nisbet JW; Ding W; Bartoe JT; Green PL; Zhang W
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1757-64. PubMed ID: 11080823
[TBL] [Abstract][Full Text] [Related]
5. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosis.
Hiraragi H; Michael B; Nair A; Silic-Benussi M; Ciminale V; Lairmore M
J Virol; 2005 Aug; 79(15):9449-57. PubMed ID: 16014908
[TBL] [Abstract][Full Text] [Related]
6. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.
Collins ND; Newbound GC; Albrecht B; Beard JL; Ratner L; Lairmore MD
Blood; 1998 Jun; 91(12):4701-7. PubMed ID: 9616168
[TBL] [Abstract][Full Text] [Related]
7. Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans.
Morozov VA; Lagaye S; Taylor GP; Matutes E; Weiss RA
J Virol; 2000 May; 74(9):3933-40. PubMed ID: 10756004
[TBL] [Abstract][Full Text] [Related]
8. In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations.
Silverman LR; Phipps AJ; Montgomery A; Fernandez S; Tsukahara T; Ratner L; Lairmore MD
Blood; 2005 Nov; 106(10):3602-8. PubMed ID: 16046523
[TBL] [Abstract][Full Text] [Related]
9. HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro.
Ye J; Silverman L; Lairmore MD; Green PL
Blood; 2003 Dec; 102(12):3963-9. PubMed ID: 12907436
[TBL] [Abstract][Full Text] [Related]
10. Source and route of exposure influence infectivity of a molecular clone of human T cell leukemia virus type I.
Simpson RM; Zhao TM; Schmidt Hubbard B; Said W; Kindt TJ
AIDS Res Hum Retroviruses; 1998 May; 14(8):711-5. PubMed ID: 9618084
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax.
Koya Y; Ohashi T; Kato H; Hanabuchi S; Tsukahara T; Takemura F; Etoh K; Matsuoka M; Fujii M; Kannagi M
J Virol; 1999 Aug; 73(8):6436-43. PubMed ID: 10400737
[TBL] [Abstract][Full Text] [Related]
12. Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.
Haynes RA; Phipps AJ; Yamamoto B; Green P; Lairmore MD
Viral Immunol; 2009 Dec; 22(6):397-405. PubMed ID: 19951176
[TBL] [Abstract][Full Text] [Related]
13. Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate.
Traina-Dorge VL; Martin LN; Lorino R; Winsor EL; Beilke MA
J Infect Dis; 2007 Feb; 195(4):562-71. PubMed ID: 17230416
[TBL] [Abstract][Full Text] [Related]
14. Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes.
Albrecht B; Collins ND; Burniston MT; Nisbet JW; Ratner L; Green PL; Lairmore MD
J Virol; 2000 Nov; 74(21):9828-35. PubMed ID: 11024109
[TBL] [Abstract][Full Text] [Related]
15. Relationship between anti-Tax antibody responses and cocultivatable virus in HTLV-I-infected rabbits.
Lydy SL; Conner ME; Marriott SJ
Virology; 1998 Oct; 250(1):60-6. PubMed ID: 9770420
[TBL] [Abstract][Full Text] [Related]
16. Early spatial and temporal events of human T-lymphotropic virus type 1 spread following blood-borne transmission in a rabbit model of infection.
Haynes RA; Zimmerman B; Millward L; Ware E; Premanandan C; Yu L; Phipps AJ; Lairmore MD
J Virol; 2010 May; 84(10):5124-30. PubMed ID: 20219918
[TBL] [Abstract][Full Text] [Related]
17. Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction.
Albrecht B; Collins ND; Newbound GC; Ratner L; Lairmore MD
J Virol Methods; 1998 Nov; 75(2):123-40. PubMed ID: 9870588
[TBL] [Abstract][Full Text] [Related]
18. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.
Murphy EL; Lee TH; Chafets D; Nass CC; Wang B; Loughlin K; Smith D;
J Infect Dis; 2004 Aug; 190(3):504-10. PubMed ID: 15243924
[TBL] [Abstract][Full Text] [Related]
19. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data.
Kwaan N; Lee TH; Chafets DM; Nass C; Newman B; Smith J; Garratty G; Murphy EL;
J Infect Dis; 2006 Dec; 194(11):1557-64. PubMed ID: 17083040
[TBL] [Abstract][Full Text] [Related]
20. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
Costa JM; Segurado AC
J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
